A bevy of news stories local and national have highlighted the ever-worsening situation for consumers , especially for folks who need so-called specialty drugs but also for the much larger segment of the population who use plain old generic medicines. While raising awareness is essential, mostly what we are seeing, is increased an amount of talk about the problem, but less often are suggestions being offered in the way of sustainable solutions. Shock over the price for new Hepatitis C drug Sovaldi was a wake-up call for policy makers and the public; it remains to be seen what will be prescribed as a remedy. Here’s a sampling of some more recent headlines:
While some in Congress have been asking why in 2014, it remains to be seen if the political will can be mustered anytime soon to secure pricing changes from Big Biopharma.